Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
about
Prognostic Impact of CT-Quantified Muscle and Fat Distribution before and after First-Line-Chemotherapy in Lung Cancer Patients.Circulating Activin A predicts survival in cancer patients.Bone Pain and Muscle Weakness in Cancer Patients.Muscle mass and association to quality of life in non-small cell lung cancer patients.The Use of Technology for Estimating Body CompositionStrengths and Weaknesses of Common Modalities in a Clinical Setting [Formula: see text].Quantifying the effect of slice thickness, intravenous contrast and tube current on muscle segmentation: Implications for body composition analysis.An analysis of the types of recently published research in the field of cachexia.Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients.Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy.Effect of sarcopenia on clinical and surgical outcome in elderly patients with proximal femur fractures.Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer.Adverse Effects of Low Preoperative Skeletal Muscle Mass in Patients Undergoing Gastrectomy for Gastric Cancer.The Obesity Paradox in Cancer-Moving Beyond BMI.Editorial: refining the estimation of fitness for surgeryDistinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosisPrognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer
P2860
Q36255549-E12BEC47-60BF-4E38-9138-052BA8940068Q38677144-71FB7EB5-A5EC-4BEE-9220-48834044CB60Q38684768-ACE83BE8-0F99-4528-82D2-7D569346C831Q38792305-A77BBED3-33F0-49C1-BB44-596AC24AB4BFQ39005185-69F335C4-C64C-478E-AE8E-623740DB2D71Q47213455-EB144770-ABE0-48A0-9A6F-623C9FDB643BQ47568983-83B63641-47B9-499A-AFD7-D48FE4739167Q47797910-4B102840-6016-4A7B-AA21-B37A087A3231Q47801764-5185176B-13AD-4DDA-80C8-5F44CE2AEC2CQ49789042-CB150AD4-5ABA-4C32-ADEA-09146F11D3BFQ50109104-53BB125B-FE50-418C-887B-661D9B0BA36FQ53310157-B703AB14-64EF-437A-90F6-322F627C7800Q53585358-B9357362-049A-4C3B-BA7F-ED2B96367F95Q58128678-5CD72763-DF35-4E08-BD80-B7A540915BFAQ58719561-C24E02A0-37FC-4A16-91E4-89110AB5616BQ58765612-5B364481-81DF-42D2-8029-3BC13A7B6C43
P2860
Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Skeletal muscle radiodensity i ...... ed non-small cell lung cancer.
@en
Skeletal muscle radiodensity i ...... ed non-small cell lung cancer.
@nl
type
label
Skeletal muscle radiodensity i ...... ed non-small cell lung cancer.
@en
Skeletal muscle radiodensity i ...... ed non-small cell lung cancer.
@nl
prefLabel
Skeletal muscle radiodensity i ...... ed non-small cell lung cancer.
@en
Skeletal muscle radiodensity i ...... ed non-small cell lung cancer.
@nl
P2093
P50
P1433
P1476
Skeletal muscle radiodensity i ...... ed non-small cell lung cancer.
@en
P2093
Bjørg Sjøblom
Bjørn H Grønberg
Marianne J Hjermstad
Marit Jordhøy
Roy M Bremnes
Vickie E Baracos
P304
P356
10.1016/J.CLNU.2016.03.010
P577
2016-04-01T00:00:00Z